TrialAmerican journal of hematology2018

A phase II study of tacrolimus and thymoglobulin as graft-versus-host-disease prophylaxis in related donor allogeneic hematopoietic cell transplantation.

Dipenkumar Modi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.